| Literature DB >> 28474330 |
Fumihiko Kinoshita1, Fumihiro Shoji2, Kazuki Takada1,3, Gouji Toyokawa1, Tatsuro Okamoto1, Tokujiro Yano4, Yoshinao Oda3, Yoshihiko Maehara1.
Abstract
Thymic mucinous adenocarcinoma is a very rare neoplasm. This tumor has a poor prognosis and its treatment is not established. In addition, the existence of KRAS mutations of thymic mucinous adenocarcinoma is still unknown, despite these mutations are common in lung mucinous adenocarcinoma. We present the case of a 79-year-old woman with primary thymic mucinous adenocarcinoma. Therefore, we reviewed clinico-pathological features of thymic mucinous adenocarcinoma in details and analyzed KRAS gene mutations of the present case.Entities:
Keywords: Clinico-pathological features; KRAS mutations; Thymic mucinous adenocarcinoma
Mesh:
Substances:
Year: 2017 PMID: 28474330 DOI: 10.1007/s11748-017-0781-1
Source DB: PubMed Journal: Gen Thorac Cardiovasc Surg ISSN: 1863-6705